HIV molecular immunology database
ITQACPKVSFEPIPHYCAPAGFAI
|
gp160(201-225) | human epitope |
TQACPKVSFEPIPIHYCAPA
|
gp160(202-221) | human epitope |
TQACPKVSFEPIPIHYCAPA
|
gp160(202-221) | human epitope |
TQACPKVSFEPIPIHYCAPA
|
gp160(202-221) | human epitope |
TQACPKVSFEPIPIHYCAPA
|
gp160(202-221) | human epitope |
TQACPKVSFEPIPIHYCAPA
|
gp160(202-221) | human epitope |
TQACPKVSFEPIPIHYCAPA
|
gp160(202-221) | human epitope |
CPKVSFEPIPIHYCA
|
gp160(205-219) | mouse epitope |
PKVTFEPIPIRYCAP
|
gp160(206-220) | A*29:02 human epitope |
PKVsFEPIPIhYCAP
|
gp160(206-220) | non-susceptible form |
PKVSFEPIPIHYCAP
|
gp160(206-220) | human, mouse epitope |
KVSFDPIPIHYCAPAGYA
|
gp160(207-224) | C*04 human epitope |
KVSFDPIPIHYCAPAGYA
|
gp160(207-224) | C*04:01 human epitope |
VSFEPIPIHY
|
gp160(208-217) | A29 human epitope |
VSFEPIPIHY
|
gp160(208-217) | A29 human epitope |
VSFEPIPIHY
|
gp160(208-217) | A29 human epitope |
VSFEPIPPHYCA
|
gp160(208-219) | A2 human epitope |
VSFEPIPPHYCA
|
gp160(208-219) | A2 human epitope |
SFDPIPIHY
|
gp160(209-217) | A*29 human epitope |
SFnPIPIHY
|
gp160(209-217) | observed variant |
tFDPIPIHY
|
gp160(209-217) | literature escape |
SFDPlPIHY
|
gp160(209-217) | observed variant |
SFDPIPIHY
|
gp160(209-217) | A*29 human epitope |
SFEPIPIHY
|
gp160(209-217) | A*29 epitope |
SFEPIPIHY
|
gp160(209-217) | A*29 human epitope |
SFEPIPIHY
|
gp160(209-217) | A29 human epitope |
SFDPIPIHY
|
gp160(209-217) | A29 human epitope |
SFEPIPIHY
|
gp160(209-217) | A29 human epitope |
SFDPIPIHY
|
gp160(209-217) | A29 human epitope |
SFEPIPIHY
|
gp160(209-217) | A29 human epitope |
SFEPIPIHY
|
gp160(209-217) | A29 human epitope |
SFEPIPIHY
|
gp160(209-217) | A*29:02 human epitope |
SFEPIPIHY
|
gp160(209-217) | A*29:02 human epitope |
SFEPIPIHY
|
gp160(209-217) | A*29:02 human epitope |
SFdPIPIHY
|
gp160(209-217) | diminished response |
SFEPIPIHf
|
gp160(209-217) | diminished response |
SiEPIPIHf
|
gp160(209-217) | diminished response |
tFEPIPIHY
|
gp160(209-217) | diminished response |
SsEPIPIHY
|
gp160(209-217) | observed variant |
SFEPIPInY
|
gp160(209-217) | observed variant |
SFEPIPIdf
|
gp160(209-217) | observed variant |
SFEPIPIHY
|
gp160(209-217) | B*14 human epitope |
SFEPIPIHY
|
gp160(209-217) | B*58:01 human epitope |
SFEPIPIHY
|
gp160(209-217) | B*82 human epitope |
SFEPIPIHY
|
gp160(209-217) | C*18 human epitope |
SFDPIPIHF
|
gp160(209-217) | human epitope |
SFEPIPIHY
|
gp160(209-217) | human epitope |
SFEPIPIHY
|
gp160(209-217) | human epitope |
SFEPIPIHY
|
gp160(209-217) | human, mouse epitope |
PIPIHYCAPAGFAIL
|
gp160(212-226) | human epitope |
PIPIHYCAPAGFAILKCNNK
|
gp160(212-231) | A2 human epitope |
PIPIHYCAPAGFAILKCNNK
|
gp160(212-231) | A2 human epitope |
PIPIHYCAPAGFAILKCNNK
|
gp160(212-231) | B57 human epitope |
PIPIHYCAPAGFAILKCNNK
|
gp160(212-231) | human epitope |
PIPIHYCAPAGFAILKCNNK
|
gp160(212-231) | human epitope |
PIPIHYCAPAGFAILKCNNK
|
gp160(212-231) | human epitope |
IPIHYCAPA
|
gp160(213-221) | B*07:02 human epitope |
IPIHYCAPA
|
gp160(213-221) | B7 human epitope |
IPIHYCAPA
|
gp160(213-221) | B7 human epitope |
IPIHYCAPA
|
gp160(213-221) | B7 supertype human, mouse epitope |
IPIHYCAPAGFAILKCNN
|
gp160(213-230) | human epitope |
IPIHYCAPAGFAILKCNdKK
|
gp160(213-230) | observed variant |
IPIHYCAPAGFAILKCNDKK
|
gp160(213-232) | human epitope |
IPIHYCAPAGFAILKCNn
|
gp160(213-232) | observed variant |
IHYCAPAGYAILKCNNKTF
|
gp160(215-233) | C*12 human epitope |
HYCAPAGFAIL
|
gp160(216-226) | human epitope |
YCAPAGFAIL
|
gp160(217-226) | C*01 human epitope |
YCAPAGFAIi
|
gp160(217-226) | escape documented in this paper; replicative capacity is not abrogated |
YCAPAGlAIi
|
gp160(217-226) | escape documented in this paper |
YCtPAGFAIi
|
gp160(217-226) | escape documented in this paper |
YCAPAGFAni
|
gp160(217-226) | escape documented in this paper |
YCAPAGFtIi
|
gp160(217-226) | escape documented in this paper |
YCAPAGFAIL
|
gp160(217-226) | C*01 human epitope |
YCAPAGFAIL
|
gp160(217-226) | C*01:02 human epitope |
YCAPAGFAIL
|
gp160(217-226) | C*01:02 human epitope |
YCAPAGFAIi
|
gp160(217-226) | escape documented in this paper |
YCAPAGFAIL
|
gp160(217-226) | C*01:02 human epitope |
YCAPAGFAIi
|
gp160(217-226) | escape documented in this paper |
YCAPAGFAIL
|
gp160(217-226) | C*01:02 human epitope |
YCAPAGFAIL
|
gp160(217-226) | C*01:02 human epitope |
YCAPAGFAIi
|
gp160(217-226) | escape documented in this paper |
YCAPAGFAIL
|
gp160(217-226) | Cw1 human epitope |
CAPAGFAIL
|
gp160(218-226) | C*01 human epitope |
CAPAGFAIL
|
gp160(218-226) | Cw1 human epitope |
CtPAGFAIL
|
gp160(218-226) | susceptible form |
CtPAGFtIL
|
gp160(218-226) | escape documented in this paper |
CtPAGFvIL
|
gp160(218-226) | escape documented in this paper |
CAPAGFAIL
|
gp160(218-226) | human epitope |
CtPAGFAIL
|
gp160(218-226) | susceptible form; subtype-specific susceptible form |
CAPAGyAIL
|
gp160(218-226) | susceptible form; subtype-specific susceptible form |
CTPAGYAILKC
|
gp160(218-228) | human epitope |